Mitesco, Inc. (MITI) Stock Analysis
Educational signal · not a buy or sell recommendation · How to read this
Beta 4.91: the stock has moved about 391% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerMitesco, Inc. (MITI) trades at $0.04. Mitesco, Inc. operates healthcare clinics under "The Good Clinic" brand, offering wellness, mental health, acute care, dermatology, and nutritional products primarily in North East Minneapolis. Sector: Healthcare.
Price as of Sep 11, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for MITI: MITI does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MITI against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
MITI: the 2 scored disciplines are evenly split. Dominant signal: Ken Griffin bearish.
How is this calculated? →AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Mitesco, Inc. (MITI) Healthcare & Pipeline Overview
Mitesco, Inc. operates "The Good Clinic" network in North East Minneapolis, providing diverse healthcare services including wellness, mental health, and acute care. The company, formerly True Nature Holding, Inc., focuses on accessible community healthcare while navigating the complexities of its OTC Other market listing and significant unprofitability.
What Is the Investment Thesis for MITI?
Mitesco, Inc. operates "The Good Clinic" network, positioning itself within the accessible healthcare services market, which is experiencing increasing demand. The company's value proposition is rooted in its integrated service model, offering wellness guidance, mental health support, acute care, dermatological treatments, and nutritional products from community-based clinics primarily in North East Minneapolis. Key growth catalysts for Mitesco could include the strategic expansion of its clinic footprint beyond its current localized presence, leveraging the growing consumer preference for convenient and holistic healthcare solutions. Additionally, enhancing patient volume through targeted community engagement and optimizing operational efficiencies to convert patient visits into sustainable revenue streams are critical. However, the investment thesis is significantly challenged by the company's current financial profile, marked by an extremely negative profit margin of -17182.3% and a gross margin of -192.3%. The very small market capitalization of $868,000 indicates substantial liquidity and financial stability risks. The company's ability to secure additional funding and demonstrate a clear pathway to profitability will be paramount for any potential long-term value creation, especially given its listing on the OTC Other tier, which implies higher risk and reduced transparency.
Based on FMP financials and quantitative analysis
MITI Key Highlights
Market Capitalization of $868,000, indicating a micro-cap status with potential liquidity challenges.
- Profit Margin of -17182.3%, reflecting significant operational losses relative to revenue.
- Gross Margin of -192.3%, suggesting that the cost of goods sold and direct service provision far exceeds revenue.
- Beta of 4.91, indicating high volatility compared to the broader market.
- Small operational footprint with only 3 employees, suggesting a lean organizational structure.
Who Are MITI's Competitors?
MITI is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MGRX Mangoceuticals, Inc. | $0.39 | +1.51% | $6.63M | — |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | $0.49 | -1.32% | $9.00M | — |
| BBLN Babylon Holdings Limited | $0.55 | -13.99% | $14.1M | — |
| SCNX Scienture Holdings, Inc. | $0.36 | -2.62% | $14.5M | — |
| BEAT HeartBeam, Inc. | $0.40 | -2.14% | $22.3M | — |
| EUDA EUDA Health Holdings Limited | $13.12 | +0.15% | $24.5M | — |
| AKLI Akili, Inc. | $0.43 | +0.25% | $34.1M | — |
| ONMD OneMedNet Corporation | $0.67 | -1.84% | $38.0M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MITI's Key Strengths?
Diverse service offerings including wellness, mental health, acute care, and dermatology.
- Focus on accessible, community-based healthcare through "The Good Clinic" network.
- Established brand presence in North East Minneapolis for local patient recognition.
What Are MITI's Weaknesses?
Extremely negative profit margin (-17182.3%) and gross margin (-192.3%).
- Very small market capitalization ($868,000) indicating significant financial instability and liquidity risk.
- Limited geographic reach, primarily concentrated in North East Minneapolis.
- Small employee base of 3, potentially limiting operational capacity and scalability.
- OTC Other tier listing, associated with higher risk and lower transparency.
What Could Drive MITI Stock Higher?
Expansion of "The Good Clinic" network into new geographical areas beyond North East Minneapolis.
- Introduction of new specialized healthcare services or wellness programs to diversify offerings.
- Securing additional funding or strategic partnerships to support operations and growth initiatives.
- Efforts to improve operational efficiency and reduce significant negative margins towards profitability.
What Are the Key Risks for MITI?
Inability to achieve profitability given current -17182.3% profit margin and -192.3% gross margin.
- Significant liquidity and financial stability risks due to a very small market capitalization of $868,000.
- Challenges in securing further funding necessary for sustained operations and growth.
- High operational costs relative to revenue, as indicated by persistent negative gross margins.
- Intense competition from established healthcare providers in the Minneapolis market, limiting market share growth.
What Are the Growth Opportunities for MITI?
- Geographic Expansion of Clinic Network: Mitesco, Inc. currently operates its "The Good Clinic" network primarily in North East Minneapolis. A significant growth opportunity lies in expanding this network to other underserved or high-demand urban and suburban areas within Minnesota and potentially beyond. The increasing demand for accessible, localized healthcare services provides a favorable market backdrop for such expansion. By strategically identifying new locations with demographic profiles that align with its integrated service model (wellness, mental health, acute care), Mitesco could tap into new patient bases and increase its overall market penetration. This expansion would leverage the established "Good Clinic" brand and operational model, aiming to replicate its community-focused approach across new territories over the next 3-5 years.
- Enhancement and Diversification of Service Offerings: While Mitesco already offers a diverse range of services, there is an opportunity to deepen existing offerings or introduce new specialized services based on community needs and emerging healthcare trends. For instance, expanding mental health services to include more specialized therapies or integrating chronic disease management programs could attract a broader patient demographic. Furthermore, leveraging technology to offer hybrid care models, such as limited telehealth consultations for follow-ups or specific wellness coaching, could extend reach without requiring immediate physical expansion. This strategic diversification would aim to increase the average revenue per patient and enhance the clinics' competitive positioning over the next 2-4 years.
- Strategic Partnerships with Healthcare Payers and Systems: Collaborating with local health insurance providers or larger regional healthcare systems presents a substantial growth avenue. Such partnerships could significantly increase patient referrals, streamline billing processes, and potentially lead to more favorable reimbursement rates. By integrating "The Good Clinic" network into broader healthcare ecosystems, Mitesco could secure a more stable patient flow and enhance its credibility within the medical community. These alliances could also provide access to shared resources or specialized expertise, bolstering the clinics' capabilities and market reach. Pursuing these partnerships could yield benefits within a 1-3 year timeframe.
- Focus on High-Demand Niche Services: The current offerings include mental health support and wellness guidance, which are areas experiencing significant and sustained demand growth. Mitesco could strategically amplify its focus on these specific high-demand niches, investing further in specialized personnel, programs, and marketing to become a recognized leader in these areas within its operational footprint. By positioning "The Good Clinic" as a premier destination for holistic wellness and accessible mental health services, the company could attract a dedicated patient base willing to seek out specialized care. This targeted approach could differentiate Mitesco from more generalized primary care providers and drive patient volume over the next 1-2 years.
- Optimization of Nutritional Product Sales and Integration: Mitesco's inclusion of nutritional products within its offerings presents an opportunity for revenue enhancement and a stronger holistic health brand. By carefully curating a selection of high-quality, evidence-based nutritional supplements and products, and integrating their recommendation directly into wellness and acute care consultations, the company can drive ancillary revenue. Educating patients on the benefits and proper use of these products, potentially through workshops or personalized plans, could increase adoption and repeat purchases. Expanding the range of products to meet diverse dietary needs and preferences could further capitalize on this revenue stream, contributing to improved gross margins over the next 1-3 years.
What Threats Does MITI Face?
- Intense competition from larger, more established healthcare providers and systems.
- Challenges in securing sufficient funding to cover significant operational losses and support growth.
- Regulatory changes in the healthcare sector impacting operations or reimbursement.
- Economic downturns affecting consumer healthcare spending and patient volumes.
- Difficulty in attracting and retaining skilled healthcare professionals with a small employee base.
What Are MITI's Competitive Advantages?
- Localized brand recognition for "The Good Clinic" in its operating region.
- Integrated service model offering a diverse range of healthcare and wellness services under one roof.
- Community-based presence, fostering patient convenience and accessibility in specific neighborhoods.
What Does MITI Do?
Mitesco, Inc., headquartered in Saint Louis Park, Minnesota, oversees a network of healthcare facilities operating under "The Good Clinic" brand. These clinics are strategically situated primarily in North East Minneapolis, United States, establishing a localized presence designed to enhance patient accessibility to a diverse array of medical and wellness services. The core mission of "The Good Clinic" network is to provide integrated, community-focused healthcare. Their service portfolio is extensive, beginning with comprehensive wellness guidance programs that emphasize preventative care, healthy lifestyle choices, and long-term well-being. Recognizing the increasing importance of mental health, the clinics offer dedicated mental health support services, aiming to provide accessible resources for psychological well-being within the local community. Beyond preventative and mental health, Mitesco's facilities deliver acute care, addressing immediate medical needs such as common illnesses, minor injuries, and urgent health concerns, thereby serving as a crucial local point of contact for primary medical attention. Furthermore, the clinics provide specialized dermatological treatments, catering to a range of skin health issues with professional care. Complementing these medical services, Mitesco, Inc. also offers a selection of nutritional products, aligning with a holistic approach to patient health that integrates diet and lifestyle with medical treatment. This multi-faceted approach positions "The Good Clinic" as a comprehensive local healthcare provider. The company's corporate history includes its prior operation as True Nature Holding, Inc., before a significant corporate transition led to its rebranding as Mitesco, Inc. in April 2020. This change marked a strategic pivot towards its current operational model, focusing on developing and managing its network of community-based clinics to meet the evolving healthcare needs of its target demographic in the Minneapolis area.
What Products and Services Does MITI Offer?
- Operate a network of healthcare facilities under "The Good Clinic" brand.
- Provide wellness guidance programs focused on preventative health.
- Offer mental health support services to the community.
- Deliver acute care services for common illnesses and minor injuries.
- Conduct dermatological treatments for various skin health concerns.
- Distribute nutritional products as part of a holistic health approach.
- Primarily serve communities in North East Minneapolis, United States.
- Headquartered in Saint Louis Park, Minnesota.
How Does MITI Make Money?
- Generate revenue through fees for diverse healthcare services provided at "The Good Clinic" facilities.
- Derive income from the sale of nutritional products to patients and consumers.
- Operate a network of physical clinics, offering an integrated model of care.
- Focus on community-based, accessible healthcare to attract and retain patients.
What Industry Does MITI Operate In?
Mitesco, Inc. operates within the Medical - Healthcare Information Services industry, specifically focusing on the provision of direct healthcare services through its network of clinics. The broader healthcare sector is characterized by ongoing trends towards increased demand for accessible, localized, and integrated care models, particularly in urban and suburban communities. There is a growing emphasis on preventative health, mental wellness, and convenient primary care solutions. Mitesco's "The Good Clinic" model positions it to address these needs by offering a diverse range of services, including wellness guidance, mental health support, and acute care, all under one roof. The competitive landscape in this segment is fragmented, consisting of numerous local primary care practices, specialized clinics, and larger integrated health systems. Mitesco's challenge lies in carving out market share and achieving profitability amidst established players and the capital-intensive nature of healthcare provision.
Who Are MITI's Key Customers?
- Individuals seeking primary medical care and acute treatment.
- Patients requiring mental health support and counseling.
- Consumers interested in wellness guidance and preventative health programs.
- Customers purchasing nutritional products for health and well-being.
- Residents primarily located in North East Minneapolis and surrounding areas.
Research confidence
Enough evidence to be useful, with gaps worth knowing about.
- ● Scoring coverage unknown
- ● Price is current
- ● Latest filing 25 days ago
- ● No analyst coverage
MoonshotScore History
Recorded daily since 2026-08-23 · 19 snapshots
| 2026-08-23 | 45 |
| 2026-08-26 | 45 |
| 2026-08-29 | 45 |
| 2026-09-01 | 45 |
| 2026-09-04 | 45 |
| 2026-09-07 | 45 |
| 2026-09-10 | 45 |
What changed?
The score has stayed at 45.
Over the same 18 days the stock moved +33.3%.
Key Financial Metrics
Return on equity for Mitesco, Inc. stands at 16.0%, a gauge of how efficiently it converts shareholder capital into profit. Its free cash flow yield is -96.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
MITI Revenue & Earnings Trend
In Q2 FY2026, MITI generated $20K in top-line revenue, marking a sequential increase of 566.7%. The company recorded a net loss of $977K, with diluted EPS of $-0.05.
Company Profile
Mitesco, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Vero Beach, US. The company is led by CEO Brian Valania. MITI has traded publicly since 2012.
Financial Health
Mitesco, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
Insider Activity
Over the past six months, Mitesco, Inc. insiders filed 4 SEC Form 4 transactions — 0 sales and 4 purchases. On net that is roughly 3.2M shares acquired (about $123K) — insiders putting money in tends to read as conviction.
MITI Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Diverse service offerings including wellness, mental health, acute care, and dermatology.
- Focus on accessible, community-based healthcare through "The Good Clinic" network.
- Established brand presence in North East Minneapolis for local patient recognition.
- Upcoming: Expansion of "The Good Clinic" network into new geographical areas beyond North East Minneapolis.
Bear Case
- Extremely negative profit margin (-17182.3%) and gross margin (-192.3%).
- Very small market capitalization ($868,000) indicating significant financial instability and liquidity risk.
- Limited geographic reach, primarily concentrated in North East Minneapolis.
- Small employee base of 3, potentially limiting operational capacity and scalability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 FY2026 | $20,000 | -$977,384 | -$0.05 |
| Q3 FY2025 | $3,000 | -$3M | -$0.27 |
Q2 FY2026 · filed 17 Aug 2026 · SEC EDGAR →
Based on FMP financials and quantitative analysis
MITI Latest News
-
Mitesco Names National Sales Manager, Regional Roll Out for Software Apps Slated for Q4
globenewswire.com · Sep 3, 2026
-
Mitesco, Inc. Announces Availability of Discussion with Sales Training Expert Brian Moses, Regarding Robo Agent, Mitesco's AI-Powered Sales Force Solution: What It Is and Why It Matters
globenewswire.com · Aug 20, 2026
-
Mitesco Identifies Strategic Growth Path Linking AI and Edge Computing Efficiency to the Connected Home Market
globenewswire.com · Aug 18, 2026
-
Mitesco Announces Capital Structure Improvements for the Benefit of Shareholders
Yahoo! Finance: MITI News · Aug 10, 2026
MITI Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for MITI.
Price Targets
Wall Street price target analysis for MITI.
MITI MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for MITI; grades run from A+ (80-100) to F (below 30).
Latest News
Mitesco Names National Sales Manager, Regional Roll Out for Software Apps Slated for Q4
Mitesco, Inc. Announces Availability of Discussion with Sales Training Expert Brian Moses, Regarding Robo Agent, Mitesco's AI-Powered Sales Force Solution: What It Is and Why It Matters
Mitesco Identifies Strategic Growth Path Linking AI and Edge Computing Efficiency to the Connected Home Market
Mitesco Announces Capital Structure Improvements for the Benefit of Shareholders
Leadership: Brian Valania
CEO
Brian Valania serves as the Chief Executive Officer of Mitesco, Inc., leading a small team of three employees. Details regarding Mr. His current role involves overseeing the strategic direction and operational management of Mitesco's network of "The Good Clinic" facilities, which are focused on delivering integrated healthcare services in North East Minneapolis. His leadership is central to navigating the company's current operational challenges and pursuing its growth objectives within the competitive healthcare landscape.
Track Record: Under Mr. Valania's leadership, Mitesco, Inc. continues to operate its network of "The Good Clinic" facilities, maintaining its presence in North East Minneapolis. Specific achievements, strategic decisions, or significant company milestones directly attributable to his tenure are not detailed in the provided information. His ongoing role involves managing the company's day-to-day operations and addressing its financial performance, including the significant negative profit and gross margins, while aiming to capitalize on the demand for accessible healthcare services.
MITI OTC Market Information
Mitesco, Inc. trades on the OTC Other tier, which represents the lowest and riskiest segment of the over-the-counter market. Unlike companies listed on major exchanges such as the NYSE or NASDAQ, which adhere to stringent listing requirements regarding financial health, corporate governance, and minimum share prices, companies on the OTC Other tier have minimal to no reporting requirements with the SEC. This classification typically includes companies with limited public information, distressed financials, or those that have failed to meet the standards of higher OTC tiers. Investors in OTC Other stocks face significantly higher risks due to the lack of transparency and regulatory oversight.
- OTC Tier: OTC Other
- Lack of consistent public financial disclosure and regulatory oversight.
- Extremely low trading volume and wide bid-ask spreads, leading to poor liquidity.
- High price volatility due to limited market depth and speculative trading.
- Limited access to capital markets for fundraising, hindering growth and operational stability.
- Increased potential for fraud or manipulation due to minimal regulatory scrutiny.
- Verify any available financial statements and audit reports, despite unknown disclosure status.
- Research the background and track record of management and key personnel.
- Thoroughly understand the company's business operations, revenue streams, and market position.
- Assess the legal and regulatory standing of the company, including any past or ongoing litigation.
- Examine trading activity, volume, and bid-ask spreads to gauge liquidity.
- Investigate any press releases or public announcements for operational updates.
- Evaluate the company's ability to secure future funding and achieve profitability.
- Clear business description operating a network of physical healthcare clinics.
- Named CEO, Brian Valania, leading the company's operations.
- Focus on providing tangible healthcare services (wellness, acute care, mental health) to a specific community.
- Prior corporate history as True Nature Holding, Inc., indicating an established entity.
What Investors Ask About Mitesco, Inc. (MITI) — Healthcare
Is MITI a good stock?
Stock Expert AI does not rate MITI buy, sell or hold. Mitesco, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.
How does Mitesco, Inc. operate within the OTC market, and what are the implications for investors?
Mitesco, Inc. trades on the OTC Other tier of the over-the-counter market, which is the lowest and riskiest segment. This classification means the company is subject to minimal regulatory oversight and disclosure requirements compared to those on major exchanges like the NYSE or NASDAQ.
What are the key factors to evaluate for MITI?
Evaluate MITI on fundamentals, analyst consensus, and risk factors. Gross Margin of -192.3%, suggesting that the cost of goods sold and direct service provision far exceeds revenue. Not financial advice.
How frequently does MITI data refresh on this page?
MITI's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven MITI's recent stock price performance?
Mitesco, Inc. (MITI) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse service offerings including wellness, mental health, acute care, and dermatology. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MITI overvalued or undervalued right now?
Mitesco, Inc. (MITI) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Can I buy fractional shares of MITI?
Yes, most major brokerages offer fractional shares of Mitesco, Inc. (MITI) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track MITI's earnings and financial reports?
Mitesco, Inc. (MITI) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Your brokerage can send alerts for MITI earnings announcements.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available beyond key metrics provided.
- Specific details on CEO background, operational history, and market share are not explicitly stated in the source material.